NDC 68788-8384-02 - Rosuvastatin Calcium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8384
- Requested NDC
- 68788-8384-02
- Package NDCs from labels
- 68788-8384-2, 68788-8384-3, 68788-8384-6, 68788-8384-9, 68788-8384-02
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-08-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rosuvastatin Calcium - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-08-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8384-2 | Rosuvastatin Calcium | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 3 | |
| 68788-8384-3 | Rosuvastatin Calcium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 3 | |
| 68788-8384-6 | Rosuvastatin Calcium | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 3 | |
| 68788-8384-9 | Rosuvastatin Calcium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8384 | ROSUVASTATIN CALCIUM TABLET, FILM COATED [PREFERRED PHARMACEUTICALS INC.] | 2 | Current NDC, 4 package rows | 20240808_b94b5b36-c04e-45ee-b933-59c4302f2661.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8384-2 | EA - Each | 68788-8384 | 85a72e1c-af2e-4d65-bd2a-24bcd55e8876 | 1 | 2023-06-06 |
| 68788-8384-3 | EA - Each | 68788-8384 | 11646fa0-eebf-416b-a2af-33502f610474 | 1 | 2023-06-06 |
| 68788-8384-6 | EA - Each | 68788-8384 | 4ae15608-2529-41d0-a39a-2c047fd139a4 | 1 | 2023-06-06 |
| 68788-8384-9 | EA - Each | 68788-8384 | 8e95b716-49a0-4c2d-8459-559fba322f0f | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | W Aesthetics | 5b0f2c8f-d6fa-5e25-e063-6394a90a084d | 2026-09-09 | Warnings | 15FIX9V2JP |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | cb942007-6ef1-4445-8dbd-6f4972148bf1 | 2026-09-09 | Warnings, Adverse reactions | 859747 83MVU38M7Q |
| Rosuvastatin | ROSUVASTATIN | ScieGen Pharmaceuticals, Inc. | ee4933c5-0d97-494d-ac0f-2083e0100836 | 2026-09-04 | Warnings, Adverse reactions | 859424 859751 859419 859747 |
| Rosuvastatin | ROSUVASTATIN | REMEDYREPACK INC. | a370a6c2-b5cd-4aa0-b072-a5a8017a2d5b | 2026-09-04 | Warnings, Adverse reactions | 859419 |
| Rosuvastatin | ROSUVASTATIN | REMEDYREPACK INC. | ab8f6264-cf12-4523-92f1-2bd60b3da442 | 2026-09-03 | Warnings, Adverse reactions | 859751 |
| Rosuvastatin | ROSUVASTATIN | REMEDYREPACK INC. | b8b29392-85fa-417b-bd10-10ab0d07381f | 2026-09-03 | Warnings, Adverse reactions | 859747 |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | TORRENT PHARMACEUTICALS LIMITED | 6985e729-d963-4f32-89a1-727472b86daa | 2026-09-02 | Warnings, Adverse reactions | 859424 859751 859419 859747 83MVU38M7Q |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Rising Pharma Holdings, Inc. | 5c992d3d-d754-48b6-a267-1451208352ed | 2026-09-01 | Warnings, Adverse reactions | 859424 859751 859419 859747 83MVU38M7Q |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | c607da3c-47f5-4773-8391-2a7b0826d30e | 2026-08-31 | Warnings, Adverse reactions | 859751 83MVU38M7Q |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | f230f4fe-0dbd-4062-9e11-a3e74bcdcba8 | 2026-08-31 | Warnings, Adverse reactions | 859419 83MVU38M7Q |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Aurobindo Pharma Limited | 47924917-bbd5-45de-96cb-c7ff9754da97 | 2026-08-28 | Warnings, Adverse reactions | 859424 859751 859419 859747 83MVU38M7Q |
| Rosuvastatin | ROSUVASTATIN | REMEDYREPACK INC. | 6ebaefa9-2c71-4777-8730-83cf5ae737cc | 2026-08-27 | Warnings, Adverse reactions | 859424 |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | REMEDYREPACK INC. | 94245f53-2892-4209-8c94-c32c87d5b106 | 2026-08-27 | Warnings, Adverse reactions | 859747 83MVU38M7Q |
| MZANK SUNSCREEN DAILY ULTIMATE PROTECTION SPF50 | SUNSCREEN SPF50 | Guangzhou Meixi Biotechnology Co., Ltd. | 5a0b4bd2-f6ad-35dc-e063-6294a90a8a66 | 2026-08-27 | Warnings | 15FIX9V2JP |
| Rosuvastatin | ROSUVASTATIN | Preferred Pharmaceuticals Inc. | 92a58577-b549-4143-abd0-391a07ed714d | 2026-08-27 | Warnings, Adverse reactions | 859419 83MVU38M7Q |
| Rosuvastatin | ROSUVASTATIN | Preferred Pharmaceuticals Inc. | d91dd29a-bb29-4193-a849-840f8696f658 | 2026-08-26 | Warnings, Adverse reactions | 859751 |
| MELAO Hydrating Lightweight Sunscreen | AVOBENZONE,ENSULIZOLE,HOMOSALATE,OCTISALATE,OCTOCRYLENE,TITANIUM DIOXIDE | Guangdong Aimu Biological Technology Co., Ltd | 59eeaea1-d726-99f3-e063-6394a90aeea3 | 2026-08-26 | Warnings | 15FIX9V2JP |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Preferred Pharmaceuticals, Inc. | 6ef51f7c-2899-4b09-bf8b-09e5b4ac3424 | 2026-08-26 | Warnings, Adverse reactions | ANDA208898 859751 83MVU38M7Q |
| Rosuvastatin Calcium | ROSUVASTATIN CALCIUM | Preferred Pharmaceuticals Inc. | b94b5b36-c04e-45ee-b933-59c4302f2661 | 2026-08-26 | Warnings, Adverse reactions | ANDA208898 68788-8384-3 68788-8384-2 68788-8384-9 68788-8384-6 68788-8384 68788838402 859747 5fa0226f-c827-41e8-a7fa-6b236b448cbf b94b5b36-c04e-45ee-b933-59c4302f2661 83MVU38M7Q |
| Rosuvastatin calcium | ROSUVASTATIN CALCIUM | Preferred Pharmaceuticals Inc., | e432e043-c019-4d58-94ca-7c1d85f5cd40 | 2026-08-26 | Warnings, Adverse reactions | 859424 83MVU38M7Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.